{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T12:40:48Z","timestamp":1688215248706},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,7,9]],"date-time":"2022-07-09T00:00:00Z","timestamp":1657324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,7,9]],"date-time":"2022-07-09T00:00:00Z","timestamp":1657324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s00432-022-04141-8","type":"journal-article","created":{"date-parts":[[2022,7,9]],"date-time":"2022-07-09T08:03:07Z","timestamp":1657353787000},"page":"2883-2892","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Seroprevalence study prior and post vaccination in cancer patients in principality of Andorra (COVONCO study)"],"prefix":"10.1007","volume":"149","author":[{"given":"Cristina","family":"Royo-Cebrecos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00cfa","family":"Robert-Montaner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Vilanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Bailles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"Serrano-Pons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Valero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep Maria","family":"Buldon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leticia","family":"Bermudez-de-Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Mahia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaume","family":"Pujadas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesc","family":"Cobo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep Maria","family":"Piqu\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santiago","family":"Albiol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,9]]},"reference":[{"issue":"2","key":"4141_CR1","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1001\/jamaoncol.2020.6778","volume":"7","author":"C Aschele","year":"2021","unstructured":"Aschele C, Negru ME, Pastorino A, Cavanna L, Zagonel V, Barone-Adesi F et al (2021) Incidence of SARS-CoV-2 infection among patients undergoing active antitumor treatment in Italy. JAMA Oncol 7(2):304","journal-title":"JAMA Oncol"},{"issue":"6","key":"4141_CR2","doi-asserted-by":"publisher","first-page":"e389","DOI":"10.1016\/S2352-3026(21)00110-1","volume":"8","author":"S Bird","year":"2021","unstructured":"Bird S, Panopoulou A, Shea RL, Tsui M, Saso R, Sud A et al (2021) Response to first vaccination against SARS-CoV-2 in patients with multiple myeloma. Lancet Haematol 8(6):e389\u2013e392","journal-title":"Lancet Haematol"},{"key":"4141_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2020.102102","volume":"90","author":"L Cabez\u00f3n-Guti\u00e9rrez","year":"2020","unstructured":"Cabez\u00f3n-Guti\u00e9rrez L, Custodio-Cabello S, Palka-Kotlowska M, Oliveros-Acebes E, Garc\u00eda-Navarro MJ, Khosravi-Shahi P (2020) Seroprevalence of SARS-CoV-2\u2013specific antibodies in cancer outpatients in Madrid (Spain): A single center, prospective, cohort study and a review of available data. Cancer Treat Rev 90:102102","journal-title":"Cancer Treat Rev"},{"issue":"7","key":"4141_CR4","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.3390\/jcm10071503","volume":"10","author":"L Cantini","year":"2021","unstructured":"Cantini L, Bastianelli L, Lupi A, Pinterpe G, Pecci F, Belletti G et al (2021) Seroprevalence of sars-cov-2\u2013specific antibodies in cancer patients undergoing active systemic treatment: A single-center experience from the marche region, italy. J Clin Med 10(7):1503","journal-title":"J Clin Med"},{"issue":"6","key":"4141_CR5","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1111\/bjh.17644","volume":"194","author":"O Chowdhury","year":"2021","unstructured":"Chowdhury O, Bruguier H, Mallett G, Sousos N, Crozier K, Allman C et al (2021) Impaired antibody response to COVID-19 vaccination in patients with chronic myeloid neoplasms. Br J Haematol 194(6):1010\u20131015","journal-title":"Br J Haematol"},{"key":"4141_CR6","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-20-0422","author":"M Dai","year":"2020","unstructured":"Dai M, Liu D, Liu M, Zhou F, Li G, Chen Z et al (2020) Patients with cancer appear more vulnerable to SARS-COV-2: a multi-center study during the COVID-19 outbreak. Cancer Discovery. https:\/\/doi.org\/10.1158\/2159-8290.CD-20-0422","journal-title":"Cancer Discovery."},{"key":"4141_CR7","unstructured":"Daniel P, Oran A, Eric J, Topol M (2020) Prevalence of Asymptomatic SARS-CoV-2 Infection. Ann Int Med"},{"key":"4141_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-021-00746-4","author":"M Gavriatopoulou","year":"2021","unstructured":"Gavriatopoulou M, Terpos E, Kastritis E, Briasoulis A, Gumeni S, Ntanasis-Stathopoulos I et al (2021) Low neutralizing antibody responses in WM, CLL and NHL patients after the first dose of the BNT162b2 and AZD1222 vaccine. Clin Experim Med. https:\/\/doi.org\/10.1007\/s10238-021-00746-4","journal-title":"Clin Experim Med."},{"key":"4141_CR9","first-page":"11","volume":"4","author":"DC Guven","year":"2021","unstructured":"Guven DC, Sahin TK, Kilickap S, Uckun FM (2021) Antibody responses to COVID-19 vaccination in cancer: a systematic review. Front Oncol 4:11","journal-title":"Front Oncol"},{"issue":"3","key":"4141_CR10","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s12016-017-8648-x","volume":"56","author":"S Jaillon","year":"2019","unstructured":"Jaillon S, Berthenet K, Garlanda C (2019) Sexual dimorphism in innate immunity. Clin Rev Allergy Immunol 56(3):308\u2013321","journal-title":"Clin Rev Allergy Immunol"},{"issue":"3","key":"4141_CR11","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S1470-2045(20)30096-6","volume":"21","author":"W Liang","year":"2020","unstructured":"Liang W, Guan W, Chen R, Wang W, Li J, Xu K et al (2020) Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 21(3):335\u2013337","journal-title":"Lancet Oncol"},{"issue":"8","key":"4141_CR12","doi-asserted-by":"publisher","first-page":"e542","DOI":"10.1016\/S2352-3026(21)00199-X","volume":"8","author":"SH Lim","year":"2021","unstructured":"Lim SH, Campbell N, Johnson M, Joseph-Pietras D, Collins GP, O\u2019Callaghan A et al (2021) Antibody responses after SARS-CoV-2 vaccination in patients with lymphoma. Lancet Haematol 8(8):e542\u2013e544","journal-title":"Lancet Haematol"},{"issue":"3","key":"4141_CR13","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1002\/cam4.3692","volume":"10","author":"H Liu","year":"2021","unstructured":"Liu H, Yang D, Chen X, Sun Z, Zou Y, Chen C et al (2021) The effect of anticancer treatment on cancer patients with COVID-19: A systematic review and meta-analysis. Cancer Med 10(3):1043\u20131056","journal-title":"Cancer Med"},{"issue":"8","key":"4141_CR14","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.annonc.2020.04.006","volume":"31","author":"H Miyashita","year":"2020","unstructured":"Miyashita H, Mikami T, Chopra N, Yamada T, Chernyavsky S, Rizk D et al (2020) Do patients with cancer have a poorer prognosis of COVID-19? An experience in New York City. Ann Oncol 31(8):1088\u20131089","journal-title":"Ann Oncol"},{"issue":"8","key":"4141_CR15","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.annonc.2020.04.479","volume":"31","author":"M Montopoli","year":"2020","unstructured":"Montopoli M, Zumerle S, Vettor R, Rugge M, Zorzi M, Catapano CV et al (2020) Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532). Ann Oncol 31(8):1040\u20131045","journal-title":"Ann Oncol"},{"issue":"10","key":"4141_CR16","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1158\/2159-8290.CD-20-0773","volume":"10","author":"DJ Pinato","year":"2020","unstructured":"Pinato DJ, Zambelli A, Aguilar-Company J, Bower M, Sng CCT, Salazar R et al (2020) Clinical portrait of the SARS-CoV-2 epidemic in european patients with cancer. Cancer Discov 10(10):1465\u20131474","journal-title":"Cancer Discov"},{"issue":"10250","key":"4141_CR17","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S0140-6736(20)31483-5","volume":"396","author":"M Poll\u00e1n","year":"2020","unstructured":"Poll\u00e1n M, P\u00e9rez-G\u00f3mez B, Pastor-Barriuso R, Oteo J, Hern\u00e1n MA, P\u00e9rez-Olmeda M et al (2020) Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study. The Lancet 396(10250):535\u2013544","journal-title":"The Lancet"},{"key":"4141_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2021.100119","author":"C Royo-Cebrecos","year":"2021","unstructured":"Royo-Cebrecos C, Vilanova D, L\u00f3pez J, Arroyo V, Pons M, Francisco G et al (2021) Mass SARS-CoV-2 serological screening, a population-based study in the Principality of Andorra. Lancet Region Health Europe. https:\/\/doi.org\/10.1016\/j.lanepe.2021.100119","journal-title":"Lancet Region Health Europe."},{"key":"4141_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2020.08.011","author":"KS Saini","year":"2020","unstructured":"Saini KS, Tagliamento M, Lambertini M, McNally R, Romano M, Leone M et al (2020) Mortality in patients with cancer and coronavirus disease: A systematic review and pooled analysis of 52 studies. Eur J Cancer. https:\/\/doi.org\/10.1016\/j.ejca.2020.08.011","journal-title":"Eur J Cancer."},{"issue":"6500","key":"4141_CR20","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1126\/science.abc3517","volume":"369","author":"H Salje","year":"2020","unstructured":"Salje H, Tran Kiem C, Lefrancq N, Courtejoie N, Bosetti P, Paireau J et al (2020) Estimating the burden of SARS-CoV-2 in France. Science 369(6500):208\u2013211","journal-title":"Science"},{"key":"4141_CR21","doi-asserted-by":"publisher","unstructured":"Snoeck CJ, Vaillant M, Abdelrahman T, Satagopam VP, Turner JD, Beaumont K, et al. Prevalence of SARS-CoV-2 infection in the Luxembourgish population-the CON-VINCE study. Available from: https:\/\/doi.org\/10.1101\/2020.05.11.20092916","DOI":"10.1101\/2020.05.11.20092916"},{"issue":"8","key":"4141_CR22","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.annonc.2020.04.475","volume":"31","author":"ML Solodky","year":"2020","unstructured":"Solodky ML, Galvez C, Russias B, Detourbet P, N\u2019Guyen-Bonin V, Herr A-L et al (2020) Lower detection rates of SARS-COV2 antibodies in cancer patients versus health care workers after symptomatic COVID-19. Ann Oncol 31(8):1087\u20131088","journal-title":"Ann Oncol"},{"issue":"10247","key":"4141_CR23","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S0140-6736(20)31304-0","volume":"396","author":"S Stringhini","year":"2020","unstructured":"Stringhini S, Wisniak A, Piumatti G, Azman AS, Lauer SA, Baysson H et al (2020) Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study. The Lancet 396(10247):313\u2013319","journal-title":"The Lancet"},{"issue":"10","key":"4141_CR24","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1038\/s43018-020-00129-w","volume":"1","author":"V Subbiah","year":"2020","unstructured":"Subbiah V (2020) A global effort to understand the riddles of COVID-19 and cancer. Nature Cancer 1(10):943\u2013945","journal-title":"Nature Cancer"},{"issue":"8","key":"4141_CR25","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.ccell.2021.06.002","volume":"39","author":"A Thakkar","year":"2021","unstructured":"Thakkar A, Gonzalez-Lugo JD, Goradia N, Gali R, Shapiro LC, Pradhan K et al (2021) Seroconversion rates following COVID-19 vaccination among patients with cancer. Cancer Cell 39(8):1081-1090.e2","journal-title":"Cancer Cell"},{"key":"4141_CR26","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.ejca.2021.10.013","volume":"159","author":"S Tran","year":"2021","unstructured":"Tran S, Truong TH, Narendran A (2021) Evaluation of COVID-19 vaccine response in patients with cancer: An interim analysis. Eur J Cancer 159:259\u2013274","journal-title":"Eur J Cancer"},{"key":"4141_CR27","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2020.7560","author":"M Ueda","year":"2020","unstructured":"Ueda M, Martins R, Hendrie PC, McDonnell T, Crews JR, Wong TL et al (2020) Managing cancer care during the COVID-19 pandemic: agility and collaboration toward a common goal. J Natl Comprehens Cancer Network. https:\/\/doi.org\/10.6004\/jnccn.2020.7560","journal-title":"J Natl Comprehens Cancer Network."},{"issue":"10223","key":"4141_CR28","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/S0140-6736(20)30185-9","volume":"395","author":"C Wang","year":"2020","unstructured":"Wang C, Horby PW, Hayden FG, Gao GF (2020) A novel coronavirus outbreak of global health concern. Lancet. 395(10223):470\u2013473. https:\/\/doi.org\/10.1016\/S0140-6736(20)30185-9","journal-title":"Lancet."},{"key":"4141_CR29","unstructured":"WHO Director-General\u2019s opening remarks at the media briefing on COVID-19 - 11 March 2020 [Internet]. [cited 2020 Jun 2]. Available from: https:\/\/www.who.int\/dg\/speeches\/detail\/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020"},{"issue":"8","key":"4141_CR30","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1001\/jama.2020.12839","volume":"324","author":"WJ Wiersinga","year":"2020","unstructured":"Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC (2020) Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19). JAMA 324(8):782","journal-title":"JAMA"},{"key":"4141_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.08.2312","author":"TM Wise-Draper","year":"2020","unstructured":"Wise-Draper TM, Desai A, Elkrief A, Rini BI, Flora DB, Bowles DW et al (2020) LBA71 Systemic cancer treatment-related outcomes in patients with SARS-CoV-2 infection: A CCC19 registry analysis. Ann Oncol. https:\/\/doi.org\/10.1016\/j.annonc.2020.08.2312","journal-title":"Ann Oncol"},{"key":"4141_CR32","unstructured":"World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report. Available at: https:\/\/www.who.int\/publications\/m\/item\/weekly-epidemiological-update-on-covid-19---22-february-2022."},{"issue":"8","key":"4141_CR33","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1038\/s41591-020-0949-6","volume":"26","author":"X Xu","year":"2020","unstructured":"Xu X, Sun J, Nie S, Li H, Kong Y, Liang M et al (2020) Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China. Nat Med 26(8):1193\u20131195","journal-title":"Nat Med"},{"issue":"7","key":"4141_CR34","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1001\/jamaoncol.2020.0980","volume":"6","author":"J Yu","year":"2020","unstructured":"Yu J, Ouyang W, Chua MLK, Xie C (2020) SARS-CoV-2 transmission in patients with cancer at a tertiary care hospital in Wuhan, China. JAMA Oncol 6(7):1108","journal-title":"JAMA Oncol"},{"key":"4141_CR35","doi-asserted-by":"crossref","unstructured":"Zambelli A, Fotia V, Bosetti T, Negrini G, di Croce A, Moro C, Poletti PL, Bettini AC, Arnoldi E, Messina C, Merelli B, Callegaro AP, Chiudinelli L, Mosconi S, Tondini C (2020) 1676MO Prevalence and clinical impact of asymptomatic or mildly symptomatic SARSCoV-2 infection among actively treated cancer patients during COVID-19 pandemic in Italy. Ann Oncol 31:S994. Available from: http:\/\/www.annalsofoncology.org\/article\/S0923753420417375\/fulltext","DOI":"10.1016\/j.annonc.2020.08.1741"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-022-04141-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-022-04141-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-022-04141-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T12:03:54Z","timestamp":1688213034000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-022-04141-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,9]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["4141"],"URL":"https:\/\/doi.org\/10.1007\/s00432-022-04141-8","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,9]]},"assertion":[{"value":"8 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}